
The study identified key prognostic features, including 13 crosstalk genes, such as HBEGF, FGF7, and GRN. Patients were stratified based on Risk Score, with the high-risk group showing enriched immunosuppressive pathways and higher expression of immune checkpoints PD-1, PD-L1, and CTLA4. These findings could have significant implications for prognosis and clinical treatments for OSCC patients.
Like
Save
Share